Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice

A. Khan, C. G. Ostenson, P. O. Berggren, S. Efendic

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Normoglycemic ob/ob mice were treated for 24 or 48 h with either 25 μg/day of dexamethasone or saline. After an overnight fast, the animals were killed and the pancreatic islets were incubated with 3H2O or [U- 14C]glucose or [5-3H]glucose at 5.5 and 16.7 mM glucose. Incorporation of 3H from 3H2O into carbon 2 of medium glucose and the yield of 14CO2 from [U-14C]glucose and 3H2O from [5-3H]glucose were measured. Dexamethasone treatment for 48 h significantly increased the rate of dephosphorylation of glucose in islets both at 5.5 mM (24 vs. 16%) and 16.7 mM (56 vs. 36%) glucose, whereas glucose oxidation and utilization were unaffected. Dexamethasone treatment also inhibited insulin release by ~60% at 5.5 and 16.7 mM glucose, either in the presence or absence of 10 mM arginine, but had no effect when insulin release was stimulated by 1 mM 3- isobutyl-1-methylxanthine. Moreover, 24-h treatment with dexamethasone significantly increased glucose cycling at low and high glucose concentrations in the medium and inhibited insulin responsiveness to glucose and arginine. In conclusion, short-term dexamethasone treatment increases glucose flux through glucose-6-phosphatase in islets from ob/ob mice. This effect may contribute to the decreased insulin response to glucose and arginine found in animals treated with dexamethasone.

Original languageEnglish
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume263
Issue number4 26-4
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Islets of Langerhans
Glucocorticoids
Insulin
Glucose
Dexamethasone
Arginine
Animals
1-Methyl-3-isobutylxanthine
Glucose-6-Phosphatase
Carbon

Keywords

  • dexamethasone
  • glucose oxidation
  • glucose utilization
  • glucose-6-phosphatase

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology

Cite this

Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice. / Khan, A.; Ostenson, C. G.; Berggren, P. O.; Efendic, S.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 263, No. 4 26-4, 01.01.1992.

Research output: Contribution to journalArticle

@article{a760a1244e7c4008b1deff11a15566e3,
title = "Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice",
abstract = "Normoglycemic ob/ob mice were treated for 24 or 48 h with either 25 μg/day of dexamethasone or saline. After an overnight fast, the animals were killed and the pancreatic islets were incubated with 3H2O or [U- 14C]glucose or [5-3H]glucose at 5.5 and 16.7 mM glucose. Incorporation of 3H from 3H2O into carbon 2 of medium glucose and the yield of 14CO2 from [U-14C]glucose and 3H2O from [5-3H]glucose were measured. Dexamethasone treatment for 48 h significantly increased the rate of dephosphorylation of glucose in islets both at 5.5 mM (24 vs. 16{\%}) and 16.7 mM (56 vs. 36{\%}) glucose, whereas glucose oxidation and utilization were unaffected. Dexamethasone treatment also inhibited insulin release by ~60{\%} at 5.5 and 16.7 mM glucose, either in the presence or absence of 10 mM arginine, but had no effect when insulin release was stimulated by 1 mM 3- isobutyl-1-methylxanthine. Moreover, 24-h treatment with dexamethasone significantly increased glucose cycling at low and high glucose concentrations in the medium and inhibited insulin responsiveness to glucose and arginine. In conclusion, short-term dexamethasone treatment increases glucose flux through glucose-6-phosphatase in islets from ob/ob mice. This effect may contribute to the decreased insulin response to glucose and arginine found in animals treated with dexamethasone.",
keywords = "dexamethasone, glucose oxidation, glucose utilization, glucose-6-phosphatase",
author = "A. Khan and Ostenson, {C. G.} and Berggren, {P. O.} and S. Efendic",
year = "1992",
month = "1",
day = "1",
language = "English",
volume = "263",
journal = "American Journal of Physiology - Cell Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "4 26-4",

}

TY - JOUR

T1 - Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice

AU - Khan, A.

AU - Ostenson, C. G.

AU - Berggren, P. O.

AU - Efendic, S.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Normoglycemic ob/ob mice were treated for 24 or 48 h with either 25 μg/day of dexamethasone or saline. After an overnight fast, the animals were killed and the pancreatic islets were incubated with 3H2O or [U- 14C]glucose or [5-3H]glucose at 5.5 and 16.7 mM glucose. Incorporation of 3H from 3H2O into carbon 2 of medium glucose and the yield of 14CO2 from [U-14C]glucose and 3H2O from [5-3H]glucose were measured. Dexamethasone treatment for 48 h significantly increased the rate of dephosphorylation of glucose in islets both at 5.5 mM (24 vs. 16%) and 16.7 mM (56 vs. 36%) glucose, whereas glucose oxidation and utilization were unaffected. Dexamethasone treatment also inhibited insulin release by ~60% at 5.5 and 16.7 mM glucose, either in the presence or absence of 10 mM arginine, but had no effect when insulin release was stimulated by 1 mM 3- isobutyl-1-methylxanthine. Moreover, 24-h treatment with dexamethasone significantly increased glucose cycling at low and high glucose concentrations in the medium and inhibited insulin responsiveness to glucose and arginine. In conclusion, short-term dexamethasone treatment increases glucose flux through glucose-6-phosphatase in islets from ob/ob mice. This effect may contribute to the decreased insulin response to glucose and arginine found in animals treated with dexamethasone.

AB - Normoglycemic ob/ob mice were treated for 24 or 48 h with either 25 μg/day of dexamethasone or saline. After an overnight fast, the animals were killed and the pancreatic islets were incubated with 3H2O or [U- 14C]glucose or [5-3H]glucose at 5.5 and 16.7 mM glucose. Incorporation of 3H from 3H2O into carbon 2 of medium glucose and the yield of 14CO2 from [U-14C]glucose and 3H2O from [5-3H]glucose were measured. Dexamethasone treatment for 48 h significantly increased the rate of dephosphorylation of glucose in islets both at 5.5 mM (24 vs. 16%) and 16.7 mM (56 vs. 36%) glucose, whereas glucose oxidation and utilization were unaffected. Dexamethasone treatment also inhibited insulin release by ~60% at 5.5 and 16.7 mM glucose, either in the presence or absence of 10 mM arginine, but had no effect when insulin release was stimulated by 1 mM 3- isobutyl-1-methylxanthine. Moreover, 24-h treatment with dexamethasone significantly increased glucose cycling at low and high glucose concentrations in the medium and inhibited insulin responsiveness to glucose and arginine. In conclusion, short-term dexamethasone treatment increases glucose flux through glucose-6-phosphatase in islets from ob/ob mice. This effect may contribute to the decreased insulin response to glucose and arginine found in animals treated with dexamethasone.

KW - dexamethasone

KW - glucose oxidation

KW - glucose utilization

KW - glucose-6-phosphatase

UR - http://www.scopus.com/inward/record.url?scp=0026801953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026801953&partnerID=8YFLogxK

M3 - Article

C2 - 1384356

AN - SCOPUS:0026801953

VL - 263

JO - American Journal of Physiology - Cell Physiology

JF - American Journal of Physiology - Cell Physiology

SN - 0363-6143

IS - 4 26-4

ER -